Visualization of monoaminergic neurons and neurotoxicity of MPTP in live transgenic zebrafish

Developmental Biology

Volumn 314, Issue 1, 2008, Pages 84-92

  Wen, Lu ^a   Wei, Wei ^a   Gu, Wenchao ^a   Huang, Peng ^a   Ren, Xi ^a   Zhang, Zheng ^a   Zhu, Zuoyan ^a   Lin, Shuo ^a,b   Zhang, Bo ^a  

^a Peking University   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Monoaminergic; MPTP; Parkinson's disease; Transgenic; Zebrafish

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIENCEPHALON; DOPAMINERGIC NERVE CELL; EMBRYO; EMBRYO DEVELOPMENT; HYPOTHALAMUS; INTRON; LOCUS CERULEUS; MONOAMINE NERVE CELL; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PRETECTUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAPHE NUCLEUS; REPORTER GENE; SIGNAL TRANSDUCTION; TELENCEPHALON; TRANSGENIC ANIMAL; ZEBRA FISH;

DANIO RERIO; ERINACEIDAE; MAMMALIA; PYRUS;

EID: 38549143712     PISSN: 00121606     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ydbio.2007.11.012     Document Type: Article

References (54)

1. Anichtchik O.V., et al. Neurochemical and behavioural changes in zebrafish Danio rerio after systemic administration of 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. J. Neurochem. 88 (2004) 443-453
2. Anichtchik O., et al. Distinct structure and activity of monoamine oxidase in the brain of zebrafish (Danio rerio). J. Comp. Neurol. 498 (2006) 593-610
3. Bai Q., et al. Zebrafish DJ-1 is evolutionarily conserved and expressed in dopaminergic neurons. Brain Res. 1113 (2006) 33-44
4. Beal M.F. Experimental models of Parkinson's disease. Nat. Rev., Neurosci. 2 (2001) 325-334
5. Bretaud S., et al. Sensitivity of zebrafish to environmental toxins implicated in Parkinson's disease. Neurotoxicol. Teratol. 26 (2004) 857-864
6. Bretaud S., et al. p53-dependent neuronal cell death in a DJ-1-deficient zebrafish model of Parkinson's disease. J. Neurochem. (2006)
7. Chen W., et al. Analysis of the zebrafish smoothened mutant reveals conserved and divergent functions of hedgehog activity. Development 128 (2001) 2385-2396
8. Cooper M.K., et al. Teratogen-mediated inhibition of target tissue response to Shh signaling. Science 280 (1998) 1603-1607
9. Dauer W., and Przedborski S. Parkinson's disease: mechanisms and models. Neuron 39 (2003) 889-909
10. de Lau L.M., and Breteler M.M. Epidemiology of Parkinson's disease. Lancet Neurol. 5 (2006) 525-535
11. Grunwald D.J., and Eisen J.S. Headwaters of the zebrafish-emergence of a new model vertebrate. Nat. Rev., Genet. 3 (2002) 717-724
12. Guo S., et al. Mutations in the zebrafish unmask shared regulatory pathways controlling the development of catecholaminergic neurons. Dev. Biol. 208 (1999) 473-487
13. Hara K., et al. Reversible serotoninergic neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mouse striatum studied by neurochemical and immunohistochemical approaches. Brain Res. 410 (1987) 371-374
14. Herkenham M., et al. Selective retention of MPP+ within the monoaminergic systems of the primate brain following MPTP administration: an in vivo autoradiographic study. Neuroscience 40 (1991) 133-158
15. Holzschuh J., et al. Dopamine transporter expression distinguishes dopaminergic neurons from other catecholaminergic neurons in the developing zebrafish embryo. Mech. Dev. 101 (2001) 237-243
16. Holzschuh J., et al. Genetic analysis of the roles of Hh, FGF8, and nodal signaling during catecholaminergic system development in the zebrafish brain. J. Neurosci. 23 (2003) 5507-5519
17. Hynes M., et al. Induction of midbrain dopaminergic neurons by Sonic hedgehog. Neuron 15 (1995) 35-44
18. Incardona J.P., et al. The teratogenic Veratrum alkaloid cyclopamine inhibits sonic hedgehog signal transduction. Development 125 (1998) 3553-3562
19. Kandel E.R., et al. Principles of Neural Science 1135 (1991), Elsevier, New York
20. Kaslin J., and Panula P. Comparative anatomy of the histaminergic and other aminergic systems in zebrafish (Danio rerio). J. Comp. Neurol. 440 (2001) 342-377
21. Kawakami K., et al. A transposon-mediated gene trap approach identifies developmentally regulated genes in zebrafish. Dev. Cell 7 (2004) 133-144
22. Lam C.S., et al. Zebrafish embryos are susceptible to the dopaminergic neurotoxin MPTP. Eur. J. Neurosci. 21 (2005) 1758-1762
23. Langston J.W., et al. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219 (1983) 979-980
24. Lin S. Transgenic zebrafish. Methods Mol. Biol. 136 (2000) 375-383
25. Liu Y., et al. A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter. Cell 70 (1992) 539-551
26. Lopez-Schier H., and Hudspeth A.J. A two-step mechanism underlies the planar polarization of regenerating sensory hair cells. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 18615-18620
27. Ma P.M. Catecholaminergic systems in the zebrafish: I. Number, morphology, and histochemical characteristics of neurons in the locus coeruleus. J. Comp. Neurol. 344 (1994) 242-255
28. Ma P.M. Catecholaminergic systems in the zebrafish: IV. Organization and projection pattern of dopaminergic neurons in the diencephalon. J. Comp. Neurol. 460 (2003) 13-37
29. Ma P.M., and Lopez M. Consistency in the number of dopaminergic paraventricular organ-accompanying neurons in the posterior tuberculum of the zebrafish brain. Brain Res. 967 (2003) 267-272
30. McKinley E.T., et al. Neuroprotection of MPTP-induced toxicity in zebrafish dopaminergic neurons. Brain Res. Mol. Brain Res. 141 (2005) 128-137
31. McLean D.L., and Fetcho J.R. Ontogeny and innervation patterns of dopaminergic, noradrenergic, and serotonergic neurons in larval zebrafish. J. Comp. Neurol. 480 (2004) 38-56
32. Meng A., et al. Promoter analysis in living zebrafish embryos identifies a cis-acting motif required for neuronal expression of GATA-2. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 6267-6272
33. Mitra N., et al. Dissociation of serotoninergic and dopaminergic components in acute effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Brain Res. Bull. 28 (1992) 355-364
34. Namura I., et al. MPP+ (1-methyl-4-phenylpyridine) is a neurotoxin to dopamine-, norepinephrine- and serotonin-containing neurons. Eur. J. Pharmacol. 136 (1987) 31-37
35. Perez-Otano I., et al. Extensive loss of brain dopamine and serotonin induced by chronic administration of MPTP in the marmoset. Brain Res. 567 (1991) 127-132
36. Przedborski S., et al. The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety. J. Neurochem. 76 (2001) 1265-1274
37. Rauch, G.J., et al., 2003. Submission and curation of gene expression data ZFIN on-line publication.
38. Reinhard Jr. J.F., et al. Subcellular compartmentalization of 1-methyl-4-phenylpyridinium with catecholamines in adrenal medullary chromaffin vesicles may explain the lack of toxicity to adrenal chromaffin cells. Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 8160-8164
39. Rink E., and Wullimann M.F. The teleostean (zebrafish) dopaminergic system ascending to the subpallium (striatum) is located in the basal diencephalon (posterior tuberculum). Brain Res. 889 (2001) 316-330
40. Rink E., and Wullimann M.F. Connections of the ventral telencephalon and tyrosine hydroxylase distribution in the zebrafish brain (Danio rerio) lead to identification of an ascending dopaminergic system in a teleost. Brain Res. Bull. 57 (2002) 385-387
41. Rink E., and Wullimann M.F. Development of the catecholaminergic system in the early zebrafish brain: an immunohistochemical study. Brain Res. Dev. Brain Res. 137 (2002) 89-100
42. Ryu S., et al. Genetic analysis of dopaminergic system development in zebrafish. J. Neural Transm., Suppl. (2006) 61-66
43. Ryu S., et al. Orthopedia homeodomain protein is essential for diencephalic dopaminergic neuron development. Curr. Biol. 17 (2007) 873-880
44. Son O.L., et al. Cloning and expression analysis of a Parkinson's disease gene, uch-L1, and its promoter in zebrafish. Biochem. Biophys. Res. Commun. 312 (2003) 601-607
45. Speciale S.G., et al. The neurotoxin 1-methyl-4-phenylpyridinium is sequestered within neurons that contain the vesicular monoamine transporter. Neuroscience 84 (1998) 1177-1185
46. Takada M., et al. Intracerebral MPTP injections in the rat cause cell loss in the substantia nigra, ventral tegmental area and dorsal raphe. Neurosci. Lett. 78 (1987) 145-150
47. Takahashi N., et al. VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 9938-9943
48. Teraoka H., et al. Hedgehog and Fgf signaling pathways regulate the development of tphR-expressing serotonergic raphe neurons in zebrafish embryos. J. Neurobiol. 60 (2004) 275-288
49. Thisse C., et al. Structure of the zebrafish snail1 gene and its expression in wild-type, spadetail and no tail mutant embryos. Development 119 (1993) 1203-1215
50. Varga Z.M., et al. Zebrafish smoothened functions in ventral neural tube specification and axon tract formation. Development 128 (2001) 3497-3509
51. Weihe E., et al. Three types of tyrosine hydroxylase-positive CNS neurons distinguished by DOPA decarboxylase and VMAT2 co-expression. Cell. Mol. Neurobiol. 26 (2006) 657-676
52. Wood-Kaczmar A., et al. Understanding the molecular causes of Parkinson's disease. Trends Mol. Med. 12 (2006) 521-528
53. Wu X., et al. Transcription start regions in the human genome are favored targets for MLV integration. Science 300 (2003) 1749-1751
54. Ye W., et al. FGF and Shh signals control dopaminergic and serotonergic cell fate in the anterior neural plate. Cell 93 (1998) 755-766